Key Highlights

Risk & Performance

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 45/100

Failure Rate

0.0%

0 terminated/withdrawn out of 5 trials

Success Rate

100.0%

+13.5% vs industry average

Late-Stage Pipeline

0 trials in Phase 3/4

Results Transparency

25%

1 of 4 completed trials have results

Key Signals

1 with results

Enrollment Performance

Analytics

N/A

3(60.0%)

Phase 2

1(20.0%)

Phase 1

1(20.0%)

5Total

N/A(3)

Phase 2(1)

Phase 1(1)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (5)

Showing 5 of 5 trials

NCT02634216Not ApplicableCompleted

Effects of Capros in Patients With Type-1 Diabetes

Role: collaborator

NCT01858376Not ApplicableCompleted

Effect Of Capros Supplementation On Cardiovascular Disease Risk Factors In Humans

Role: collaborator

NCT02762032Phase 1Unknown

Natreon Healthy Skin Study - PrimaVie Supplement

Role: collaborator

NCT02589249Not ApplicableCompleted

The Effect of AyuFlex® Supplementation on Joint Health

Role: collaborator

NCT01311180Phase 2Completed

A Clinical Trial to Study the Effects of Sensoril® for Patients With Generalized Anxiety Disorder

Role: lead

All 5 trials loaded